At the Malaghan Institute for Medical Research researchers are working on what they believe will be the future of cancer treatment in New Zealand.

In CAR T-cell therapy the patient’s own immune cells get equipped with a cancer detecting receptor to help them identify and kill cancer cells.

The institute is running a Phase 1 clinical trial to test a therapy they have developed on a certain type of blood cancer.

Meanwhile, the research team is busy investigating how to make the therapy safer, more effective and applicable to other types of cancer.

Claire Concannon visits the Malaghan Institute of Medical Research to find out more.

Follow Our Changing World on Apple Podcasts, Spotify, Stitcher, iHeartRADIO, , RadioPublic or wherever you listen to your podcasts